Exploring the Anticancer Potential of Novel Piperidine‐Embedded Isoxazol–Triazole Conjugates Against MCF‐7 Human Breast Adenocarcinoma Cell Line: Design, Synthesis, In Silico, and In Vitro Investigations
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Jay R Ghonia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Sardar Vallabhbhai National Institute of Technology, Surat, Gujarat, India. Hauptthemen laut MEDLINE: Triazoles, Piperidines, Antineoplastic Agents, Drug Design. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cancer remains a major global health challenge, particularly as several tumors develop resistance to current therapies. Although doxorubicin is widely used to treat various cancers, its effectiveness is often limited by adverse effects, including cardiotoxicity and nephrotoxicity, which restrict its dosing. In search of safer and more effective options, a series of novel piperidine–embedded isoxazol–triazole conjugates ( 6a‐6o ) were designed, synthesized, and biologically evaluated against the MCF‐7 cell line in this study. The synthesized compounds 6a‐6o were characterized using FTIR, HRMS, and 1 H and 13 C NMR spectroscopy analysis to confirm their structure and verify successful synthesis. The GI 50 (Growth Inhibition 50%) values of synthesized compounds 6a‐6o were determined using the SRB assay. Among all synthesized compounds, 6m exhibited the most potent antiproliferative activity against MCF‐7 cells, having GI50 5), comparable to adriamycin (doxorubicin, GI 50
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Sardar Vallabhbhai National Institute of Technology, Surat, Gujarat, India.
- Department of Chemical Engineering, Sardar Vallabhbhai National Institute of Technology, Surat, Gujarat, India.
ORCID-Profile: Jay R Ghonia, Bharatkumar Z Dholakiya
Zitieren
APA
Ghonia, J. R., Parikh, J., & Dholakiya, B. Z. (2026). Exploring the Anticancer Potential of Novel Piperidine‐Embedded Isoxazol–Triazole Conjugates Against MCF‐7 Human Breast Adenocarcinoma Cell Line: Design, Synthesis, In Silico, and In Vitro Investigations. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71702
Vancouver
Ghonia JR, Parikh J, Dholakiya BZ. Exploring the Anticancer Potential of Novel Piperidine‐Embedded Isoxazol–Triazole Conjugates Against MCF‐7 Human Breast Adenocarcinoma Cell Line: Design, Synthesis, In Silico, and In Vitro Investigations. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71702
BibTeX
@article{Ghonia2026,
author = {Ghonia, Jay R and Parikh, Jigisha and Dholakiya, Bharatkumar Z},
title = {Exploring the Anticancer Potential of Novel Piperidine‐Embedded Isoxazol–Triazole Conjugates Against MCF‐7 Human Breast Adenocarcinoma Cell Line: Design, Synthesis, In Silico, and In Vitro Investigations},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71702}
}
EUVIMED